SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Mimedx Group, Inc. – ‘10-K’ for 12/31/20 – ‘EX-23.1’

On:  Monday, 3/8/21, at 5:27pm ET   ·   For:  12/31/20   ·   Accession #:  1376339-21-11   ·   File #:  1-35887

Previous ‘10-K’:  ‘10-K’ on 7/6/20 for 12/31/19   ·   Next:  ‘10-K’ on 2/28/22 for 12/31/21   ·   Latest:  ‘10-K’ on 2/28/24 for 12/31/23   ·   29 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 3/08/21  Mimedx Group, Inc.                10-K       12/31/20  111:12M

Annual Report   —   Form 10-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML   1.58M 
 2: EX-3.1      Articles of Incorporation/Organization or Bylaws    HTML    208K 
 3: EX-10.25    Material Contract                                   HTML     42K 
 4: EX-10.35    Material Contract                                   HTML     55K 
 5: EX-21.1     Subsidiaries List                                   HTML     28K 
 6: EX-23.1     Consent of Expert or Counsel                        HTML     28K 
 7: EX-31.1     Certification -- §302 - SOA'02                      HTML     32K 
 8: EX-31.2     Certification -- §302 - SOA'02                      HTML     32K 
 9: EX-32.1     Certification -- §906 - SOA'02                      HTML     29K 
10: EX-32.2     Certification -- §906 - SOA'02                      HTML     29K 
17: R1          Cover Page                                          HTML     88K 
18: R2          Consolidated Balance Sheets                         HTML    119K 
19: R3          Consolidated Balance Sheets (Parenthetical)         HTML     61K 
20: R4          Consolidated Statements of Operations               HTML    105K 
21: R5          Consolidated Statements of Stockholders' (Deficit)  HTML     93K 
                Equity                                                           
22: R6          Consolidated Statements of Cash Flows               HTML    134K 
23: R7          Nature of Business                                  HTML     36K 
24: R8          Significant Accounting Policies                     HTML    124K 
25: R9          Inventory                                           HTML     39K 
26: R10         Property and Equipment                              HTML     51K 
27: R11         Leases                                              HTML     78K 
28: R12         Goodwill and Intangible Assets                      HTML     75K 
29: R13         Accrued Expenses                                    HTML     40K 
30: R14         Long Term Debt                                      HTML     97K 
31: R15         Net Loss Per Common Share                           HTML     73K 
32: R16         Equity                                              HTML    105K 
33: R17         Income Taxes                                        HTML    114K 
34: R18         Supplemental Disclosure of Cash Flow and Non-Cash   HTML     46K 
                Investing and Financing Activities                               
35: R19         401(k) Plan                                         HTML     34K 
36: R20         Commitments and Contingencies                       HTML     75K 
37: R21         Revenue Data by Customer Type                       HTML     41K 
38: R22         Related Party Transactions                          HTML     32K 
39: R23         Restructuring                                       HTML     39K 
40: R24         Quarterly Financial Data                            HTML     62K 
41: R25         Subsequent Events                                   HTML     30K 
42: R26         Schedule II Valuation and Qualifying Accounts       HTML     53K 
43: R27         Significant Accounting Policies (Policies)          HTML    183K 
44: R28         Significant Accounting Policies (Tables)            HTML     42K 
45: R29         Inventory (Tables)                                  HTML     40K 
46: R30         Property and Equipment (Tables)                     HTML     52K 
47: R31         Leases (Tables)                                     HTML     52K 
48: R32         Goodwill and Intangible Assets (Tables)             HTML    106K 
49: R33         Accrued Expenses (Tables)                           HTML     39K 
50: R34         Long Term Debt (Tables)                             HTML     81K 
51: R35         Net Loss Per Common Share (Tables)                  HTML     73K 
52: R36         Equity (Tables)                                     HTML     96K 
53: R37         Income Taxes (Tables)                               HTML    111K 
54: R38         Supplemental Disclosure of Cash Flow and Non-Cash   HTML     45K 
                Investing and Financing Activities (Tables)                      
55: R39         Commitments and Contingencies (Tables)              HTML     33K 
56: R40         Revenue Data by Customer Type (Tables)              HTML     38K 
57: R41         Restructuring (Tables)                              HTML     37K 
58: R42         Quarterly Financial Data (Tables)                   HTML     62K 
59: R43         Nature of Business (Details)                        HTML     42K 
60: R44         Significant Accounting Policies - Additional        HTML     69K 
                Information (Details)                                            
61: R45         Significant Accounting Policies - Assessment of     HTML     58K 
                Revenue under ASC 606 (Details)                                  
62: R46         Inventory (Details)                                 HTML     43K 
63: R47         Property and Equipment - Property and Equipment     HTML     47K 
                (Details)                                                        
64: R48         Property and Equipment - Depreciation (Details)     HTML     37K 
65: R49         Leases - Narrative (Details)                        HTML     38K 
66: R50         Leases - Supplemental Balance Sheet Information     HTML     52K 
                (Details)                                                        
67: R51         Leases - Lease Costs for Operating Leases           HTML     32K 
                (Details)                                                        
68: R52         Leases - Maturities of Operating Lease Liabilities  HTML     47K 
                (Details)                                                        
69: R53         Goodwill and Intangible Assets - Narrative          HTML     33K 
                (Details)                                                        
70: R54         Goodwill and Intangible Assets - Changes in         HTML     33K 
                Carrying Amount of Goodwill (Details)                            
71: R55         Goodwill and Intangible Assets - Intangible Assets  HTML     58K 
                Activity Summary (Details)                                       
72: R56         Goodwill and Intangible Assets - Amortization       HTML     33K 
                Expense (Details)                                                
73: R57         Goodwill and Intangible Assets - Expected Future    HTML     44K 
                Amortization of Intangible Assets (Details)                      
74: R58         Accrued Expenses (Details)                          HTML     48K 
75: R59         Long Term Debt - Term Loan (Details)                HTML    144K 
76: R60         Long Term Debt - Term Loan Debt Issuance Costs      HTML     43K 
                (Details)                                                        
77: R61         Long Term Debt - Term Loan Balances (Details)       HTML     66K 
78: R62         Long Term Debt - Term Loan Interest Expense         HTML     49K 
                (Details)                                                        
79: R63         Long Term Debt - Term Loan Maturity (Details)       HTML     46K 
80: R64         Long Term Debt - Term Loan Extinguishment of Debt   HTML     42K 
                (Details)                                                        
81: R65         Net Loss Per Common Share - Narrative (Details)     HTML     32K 
82: R66         Net Loss Per Common Share - Basic Net Loss Per      HTML     63K 
                Common Share (Details)                                           
83: R67         Net Loss Per Common Share - Diluted Net Loss Per    HTML     72K 
                Common Share (Details)                                           
84: R68         Equity - Convertible Preferred Stock Series B       HTML     67K 
                (Details)                                                        
85: R69         Equity - Changes in Series B Preferred Stock        HTML     45K 
                (Details)                                                        
86: R70         Equity - Stock Incentive Plans (Details)            HTML     62K 
87: R71         Equity - Stock Option Activity (Details)            HTML     74K 
88: R72         Equity - Modification of Stock Options (Details)    HTML     61K 
89: R73         Equity - Restricted Stock Awards (Details)          HTML     57K 
90: R74         Equity - Summary of Restricted Stock Awards         HTML     71K 
                (Details)                                                        
91: R75         Equity - Recognized Stock-Based Compensation        HTML     41K 
                (Details)                                                        
92: R76         Equity - Treasury Stock (Details)                   HTML     39K 
93: R77         Income Taxes - Narrative (Details)                  HTML     75K 
94: R78         Income Taxes - Deferred Tax Assets and Liabilities  HTML     73K 
                (Details)                                                        
95: R79         Income Taxes - Reconciliation of the Federal        HTML     60K 
                Statutory Income Tax (Details)                                   
96: R80         Income Taxes - Schedule of current and deferred     HTML     54K 
                income tax expense (Benefit) (Details)                           
97: R81         Income Taxes - Reconciliation of unrecognized tax   HTML     35K 
                benefits (Details)                                               
98: R82         Supplemental Disclosure of Cash Flow and Non-Cash   HTML     52K 
                Investing and Financing Activities (Details)                     
99: R83         401(k) Plan (Details)                               HTML     47K 
100: R84         Commitments and Contingencies - Narrative           HTML     51K  
                (Details)                                                        
101: R85         Commitments and Contingencies - Estimated Annual    HTML     35K  
                Lease, Royalty, and Employment Agreement Expenses                
                (Details)                                                        
102: R86         Revenue Data by Customer Type (Details)             HTML     43K  
103: R87         Related Party Transactions (Details)                HTML     41K  
104: R88         Restructuring - Narrative (Details)                 HTML     35K  
105: R89         Restructuring - Restructuring Reserve Liability     HTML     36K  
                (Details)                                                        
106: R90         Quarterly Financial Data (Details)                  HTML     70K  
107: R91         Schedule II Valuation and Qualifying Accounts       HTML     44K  
                (Details)                                                        
109: XML         IDEA XML File -- Filing Summary                      XML    195K  
16: XML         XBRL Instance -- mdxg-20201231_htm                   XML   2.72M 
108: EXCEL       IDEA Workbook of Financial Reports                  XLSX    152K  
12: EX-101.CAL  XBRL Calculations -- mdxg-20201231_cal               XML    343K 
13: EX-101.DEF  XBRL Definitions -- mdxg-20201231_def                XML    736K 
14: EX-101.LAB  XBRL Labels -- mdxg-20201231_lab                     XML   2.19M 
15: EX-101.PRE  XBRL Presentations -- mdxg-20201231_pre              XML   1.29M 
11: EX-101.SCH  XBRL Schema -- mdxg-20201231                         XSD    210K 
110: JSON        XBRL Instance as JSON Data -- MetaLinks              495±   722K  
111: ZIP         XBRL Zipped Folder -- 0001376339-21-000011-xbrl      Zip    610K  


‘EX-23.1’   —   Consent of Expert or Counsel


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 <!   C:   C: 
  Document  

Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

MiMedx Group, Inc.
Marietta, Georgia

We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (No. 333-153255, 333-183991, 333-189784, 333-199841, 333-211900 and 333-251434) of MiMedx Group, Inc. of our reports dated March 8, 2021, relating to the consolidated financial statements and schedule, and the effectiveness of MiMedx Group, Inc.’s internal control over financial reporting, which appear in this Form 10-K. Our report on the effectiveness of internal control over financial reporting expresses an adverse opinion on the effectiveness of the Company’s internal control over financial reporting as of December 31, 2020.


/s/ BDO USA, LLP
Atlanta, Georgia

March 8, 2021





Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-K’ Filing    Date    Other Filings
Filed on:3/8/214,  8-K
For Period end:12/31/20
 List all Filings 


10 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/28/24  Mimedx Group, Inc.                10-K       12/31/23  116:11M
 7/25/23  Mimedx Group, Inc.                S-8         7/25/23    5:94K                                    Donnelley … Solutions/FA
 7/25/23  Mimedx Group, Inc.                S-8         7/25/23    5:79K                                    Donnelley … Solutions/FA
 3/09/23  Mimedx Group, Inc.                S-8         3/09/23    5:88K                                    Donnelley … Solutions/FA
 2/28/23  Mimedx Group, Inc.                10-K       12/31/22  123:13M
 6/17/22  Mimedx Group, Inc.                S-8         6/17/22    5:85K                                    Donnelley … Solutions/FA
 2/28/22  Mimedx Group, Inc.                10-K       12/31/21  112:13M
 8/27/21  Mimedx Group, Inc.                S-3                    8:2.2M                                   Donnelley … Solutions/FA
 8/03/21  Mimedx Group, Inc.                10-Q        6/30/21   77:7.4M
 4/28/21  Mimedx Group, Inc.                10-Q        3/31/21   80:6.8M


19 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

12/21/20  Mimedx Group, Inc.                8-K:5      12/16/20   14:372K
12/17/20  Mimedx Group, Inc.                S-8        12/17/20    5:422K                                   Donnelley … Solutions/FA
11/04/20  Mimedx Group, Inc.                10-Q        9/30/20   79:7.4M
11/02/20  Mimedx Group, Inc.                8-A12B                 1:37K
 7/06/20  Mimedx Group, Inc.                10-K       12/31/19  119:16M
 3/17/20  Mimedx Group, Inc.                10-K       12/31/18  111:16M
11/21/19  Mimedx Group, Inc.                8-K:5,9    11/15/19    2:100K
 6/11/19  Mimedx Group, Inc.                8-K:1,2,9   6/10/19    2:1.1M                                   Donnelley … Solutions/FA
 5/30/19  Mimedx Group, Inc.                8-K:8,9     5/30/19   11:511K                                   Donnelley … Solutions/FA
 5/09/19  Mimedx Group, Inc.                8-K:5,7,9   5/06/19    3:112K                                   Donnelley … Solutions/FA
10/04/18  Mimedx Group, Inc.                8-K:5,9    10/03/18    2:157K                                   Donnelley … Solutions/FA
 3/13/17  Mimedx Group, Inc.                8-K:1,2,9   3/07/17    2:81K
 8/02/16  Mimedx Group, Inc.                10-Q        6/30/16   72:5.6M
 3/04/14  Mimedx Group, Inc.                10-K       12/31/13   81:10M
 3/03/14  Mimedx Group, Inc.                8-K:1,5,9   2/25/14    3:187K                                   Broadridge Fin’l So… Inc
 8/08/13  Mimedx Group, Inc.                10-Q        6/30/13  104:10M
 5/10/13  Mimedx Group, Inc.                10-Q        3/31/13   60:6M                                     Broadridge Fin’l So… Inc
 7/15/08  Mimedx Group, Inc.                8-K:1,5,9   7/09/08    3:85K                                    Bowne - BPC/FA
 2/08/08  Mimedx Group, Inc.                8-K:1,2,3,4 2/08/08   63:3.9M                                   Donnelley … Solutions/FA
Top
Filing Submission 0001376339-21-000011   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Tue., May 14, 6:55:50.4am ET